MLTX logo

MoonLake Immunotherapeutics (MLTX) Shareholders Equity

Annual Shareholders Equity:

$446.82M-$48.85M(-9.86%)
December 31, 2024

Summary

  • As of today, MLTX annual stockholders equity is $446.82 million, with the most recent change of -$48.85 million (-9.86%) on December 31, 2024.
  • During the last 3 years, MLTX annual shareholders equity has risen by +$458.47 million (+3937.05%).
  • MLTX annual shareholders equity is now -9.86% below its all-time high of $495.68 million, reached on December 31, 2023.

Performance

MLTX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Quarterly Shareholders Equity:

$353.73M-$53.79M(-13.20%)
June 30, 2025

Summary

  • As of today, MLTX quarterly stockholders equity is $353.73 million, with the most recent change of -$53.79 million (-13.20%) on June 30, 2025.
  • Over the past year, MLTX quarterly shareholders equity has dropped by -$166.93 million (-32.06%).
  • MLTX quarterly shareholders equity is now -34.80% below its all-time high of $542.55 million, reached on March 31, 2024.

Performance

MLTX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

MLTX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-9.9%-32.1%
3Y3 Years+3937.1%+456.9%
5Y5 Years+297.2%+10000.0%

MLTX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-9.9%+3937.1%-34.8%+742.2%
5Y5-Year-9.9%+3937.1%-34.8%+3137.6%
All-TimeAll-Time-9.9%+3937.1%-34.8%+3137.6%

MLTX Shareholders Equity History

DateAnnualQuarterly
Jun 2025
-
$353.73M(-13.2%)
Mar 2025
-
$407.52M(-8.8%)
Dec 2024
$446.82M(-9.9%)
$446.82M(-8.5%)
Sep 2024
-
$488.20M(-6.2%)
Jun 2024
-
$520.66M(-4.0%)
Mar 2024
-
$542.55M(+9.5%)
Dec 2023
$495.68M(+913.7%)
$495.68M(+16.6%)
Sep 2023
-
$424.93M(-13.2%)
Jun 2023
-
$489.80M(+1066.2%)
Mar 2023
-
$42.00M(-14.1%)
DateAnnualQuarterly
Dec 2022
$48.90M(+519.9%)
$48.90M(-11.6%)
Sep 2022
-
$55.29M(-13.0%)
Jun 2022
-
$63.51M(+160.4%)
Mar 2022
-
$24.39M(+309.5%)
Dec 2021
-$11.64M(-110.4%)
-$11.64M(-110.6%)
Sep 2021
-
$110.16M(-1.9%)
Jun 2021
-
$112.26M(-0.1%)
Mar 2021
-
$112.41M(-0.1%)
Dec 2020
$112.48M
$112.48M(>+9900.0%)
Sep 2020
-
$20.00K

FAQ

  • What is MoonLake Immunotherapeutics annual stockholders equity?
  • What is the all-time high annual shareholders equity for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual shareholders equity year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly shareholders equity year-on-year change?

What is MoonLake Immunotherapeutics annual stockholders equity?

The current annual shareholders equity of MLTX is $446.82M

What is the all-time high annual shareholders equity for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual stockholders equity is $495.68M

What is MoonLake Immunotherapeutics annual shareholders equity year-on-year change?

Over the past year, MLTX annual stockholders equity has changed by -$48.85M (-9.86%)

What is MoonLake Immunotherapeutics quarterly stockholders equity?

The current quarterly shareholders equity of MLTX is $353.73M

What is the all-time high quarterly shareholders equity for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly stockholders equity is $542.55M

What is MoonLake Immunotherapeutics quarterly shareholders equity year-on-year change?

Over the past year, MLTX quarterly stockholders equity has changed by -$166.93M (-32.06%)
On this page